FY25 B1 takeda pharm chemo meds SEP 25
Ended Awarded Last action
- Contract number
- 15B40626F00000002
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
Federal Correctional Complex Florence
Correctional Facilities, Department of Justice
- Obligated
- $0
Award facts
- Contract value 0% obligated
- $14,297.27 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02139, USA
Award details come from SAM.gov/FPDS.
About this award
Takeda Pharmaceuticals America, Inc., a Cambridge, Massachusetts-based subsidiary of Japanese pharmaceutical firm Takeda Pharmaceutical Company Limited, was awarded a delivery order valued at $14,297.27 by the Federal Correctional Complex Florence for chemotherapy medications. This contract, issued on October 31, 2025, utilizes a firm fixed price structure and represents a delivery order under Takeda's existing General Services Administration Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The award carries no small business set-aside designation, consistent with Takeda's classification as a large, foreign-owned business. Performance of this delivery order will be conducted from Takeda's Cambridge, Massachusetts location, with an ultimate completion date of October 31, 2025.
This delivery order falls under Takeda's broader federal contracting portfolio, which includes substantial indefinite delivery vehicles such as a $2.9 billion Federal Supply Schedule contract and a $123.5 million Blanket Purchase Agreement focused on supplying specialized pharmaceutical products to federal agencies. While Takeda has historically concentrated its federal business with the Department of Veterans Affairs, providing oncology medications to Veterans Integrated Service Networks, this award demonstrates the company's expanding role as a critical pharmaceutical supplier across the federal healthcare system, including the Bureau of Prisons.
Quick answers
Who was awarded contract 15B40626F00000002?
15B40626F00000002 was awarded to Takeda Pharmaceuticals America, Inc. by Federal Correctional Complex Florence (Correctional Facilities) on October 31, 2025.
How much is contract 15B40626F00000002 worth?
The government has obligated $0 on 15B40626F00000002. Its current value, with exercised options, is $14,297.
Is contract 15B40626F00000002 an order under another contract?
Yes. 15B40626F00000002 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15B40626F00000002 competed?
The extent of competition for 15B40626F00000002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award